Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Revelation Biosciences Inc (REVB)

Revelation Biosciences Inc (REVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,332
  • Shares Outstanding, K 5,924
  • Annual Sales, $ 0 K
  • Annual Income, $ -15,040 K
  • EBIT $ -8 M
  • EBITDA $ -8 M
  • 60-Month Beta -0.14
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.30
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -30.05
  • Most Recent Earnings $-1.77 on 11/06/25
  • Next Earnings Date 03/05/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.92
  • Number of Estimates 2
  • High Estimate -0.33
  • Low Estimate -1.50
  • Prior Year -14.94
  • Growth Rate Est. (year over year) +93.84%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7600 +18.41%
on 12/31/25
0.9930 -9.38%
on 12/16/25
-0.0601 (-6.26%)
since 12/15/25
3-Month
0.7600 +18.41%
on 12/31/25
1.4000 -35.72%
on 10/16/25
-0.4601 (-33.83%)
since 10/15/25
52-Week
0.7600 +18.41%
on 12/31/25
23.5200 -96.17%
on 01/16/25
-22.6201 (-96.17%)
since 01/15/25

Most Recent Stories

More News
Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026)

- Presentation to Include Additional Positive Data from the Recently Completed PRIME Clinical Study -

REVB : 0.8999 (-0.01%)
Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, CA / ACCESS Newswire / January 12, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing inflammation,...

REVB : 0.8999 (-0.01%)
Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development

SAN DIEGO, CA / ACCESS Newswire / January 7, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing inflammation,...

REVB : 0.8999 (-0.01%)
Revelation Biosciences Has Reached A Quorum For Its December 3, 2025 Special Meeting

SAN DIEGO, CALIFORNIA / ACCESS Newswire / December 1, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation,...

REVB : 0.8999 (-0.01%)
Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year

SAN DIEGO, CA / ACCESS Newswire / November 20, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing inflammation,...

REVB : 0.8999 (-0.01%)
Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2025

SAN DIEGO, CALIFORNIA / ACCESS Newswire / November 6, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing...

REVB : 0.8999 (-0.01%)
Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date

SAN DIEGO, CA / ACCESS Newswire / October 29, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation,...

REVB : 0.8999 (-0.01%)
Revelation Biosciences Adjourns Special Stockholders Meeting

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Revelation...

REVB : 0.8999 (-0.01%)
Revelation Biosciences Inc. Announces Adjournment of October 15, 2025 Special Meeting of Stockholders to October 29, 2025

SAN DIEGO, CA, CA / ACCESS Newswire / October 15, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation,...

REVB : 0.8999 (-0.01%)
Revelation Biosciences Inc. Announces Exercise of Warrants for $9.6 Million in Gross Proceeds

SAN DIEGO, CA / ACCESS Newswire / September 11, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation,...

REVB : 0.8999 (-0.01%)

Business Summary

Revelation Biosciences Inc. is a clinical-stage life sciences company. It focused on the development of immunologic-based therapies for the prevention and treatment of disease. The company's product pipeline includes REVTx-99, REVTx-200 and REVDx-501. Revelation Biosciences Inc., formerly known as Petra...

See More

Key Turning Points

3rd Resistance Point 0.9257
2nd Resistance Point 0.9167
1st Resistance Point 0.9083
Last Price 0.8999
1st Support Level 0.8909
2nd Support Level 0.8819
3rd Support Level 0.8735

See More

52-Week High 23.5200
Fibonacci 61.8% 14.8257
Fibonacci 50% 12.1400
Fibonacci 38.2% 9.4543
Last Price 0.8999
52-Week Low 0.7600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar